ArticleInternational journal of cardiology. Heart & vasculature2026
Determinants of cancer mortality in patients after acute myocardial infarction.
Article in International journal of cardiology. Heart & vasculature, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To identify factors and preexisting conditions that are associated with overall cancer mortality, lung cancer mortality, and gastrointestinal cancer mortality in patients after acute myocardial infarction (AMI). Methods: In total 10,718 AMI patients aged 25 to 74 years were evaluated. All cases of AMI that occurred in the study region of the population-based Myocardial Infarction Registry Augsburg during the period from 2000 to 2017 were analyzed. Median follow-up time was 6.6 years (IQR 2.8-11.2). Multivariable Cox regression models were calculated for overall cancer mortality (ICD-10: C00-D48), lung cancer mortality (C34), and gastrointestinal cancer mortality (C15-C25). Results: During the study period, 633 patients died from cancer, including 155 deaths from lung cancer and 212 deaths from gastrointestinal cancer. Higher age, current smoking and diabetes were associated with an increased cancer mortality risk in patients after AMI, whereas female sex, never smoking and platelet aggregation inhibitor intake were inversely related to overall cancer mortality. Higher lung cancer mortality in patients after AMI was linked with advanced age and current smoking. For gastrointestinal cancer death in patients after AMI age, diabetes and current smoking were associated with higher risk, whereas female sex, never smoking, platelet aggregation inhibitor and statin intake were inversely associated. Conclusion: Factors already known for preventing cardiovascular disease were inversely associated with cancer mortality after AMI. These findings support the importance of comprehensive patient education regarding a healthy lifestyle following AMI. Overall, physicians targeting secondary prevention after AMI can also highlight the positive effects of these measures on cancer mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.